These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


80 related items for PubMed ID: 20803623

  • 1. Synthesis, in-vitro cytotoxicity, and a preliminary structure-activity relationship investigation of pyrimido[4,5-c]quinoline-1(2H)-ones.
    Metwally K, Khalil A, Pratsinis H, Kletsas D.
    Arch Pharm (Weinheim); 2010 Aug; 343(8):465-72. PubMed ID: 20803623
    [Abstract] [Full Text] [Related]

  • 2. Pyrimido[4,5-c]quinolin-1(2H)-ones as a novel class of antimitotic agents: Synthesis and in vitro cytotoxic activity.
    Metwally K, Pratsinis H, Kletsas D.
    Eur J Med Chem; 2007 Mar; 42(3):344-50. PubMed ID: 17141923
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and antiproliferative evaluation of certain pyrido[3,2-g]quinoline derivatives.
    Li SY, Chen YL, Wang C, Tzeng CC.
    Bioorg Med Chem; 2006 Nov 15; 14(22):7370-6. PubMed ID: 16887354
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and antiproliferative evaluation of certain 4-anilino-8-methoxy-2-phenylquinoline and 4-anilino-8-hydroxy-2-phenylquinoline derivatives.
    Chen YL, Huang CJ, Huang ZY, Tseng CH, Chang FS, Yang SH, Lin SR, Tzeng CC.
    Bioorg Med Chem; 2006 May 01; 14(9):3098-105. PubMed ID: 16412647
    [Abstract] [Full Text] [Related]

  • 5. Synthesis of a new 4-aza-2,3-didehydropodophyllotoxin analogues as potent cytotoxic and antimitotic agents.
    Kamal A, Suresh P, Mallareddy A, Kumar BA, Reddy PV, Raju P, Tamboli JR, Shaik TB, Jain N, Kalivendi SV.
    Bioorg Med Chem; 2011 Apr 01; 19(7):2349-58. PubMed ID: 21402478
    [Abstract] [Full Text] [Related]

  • 6. Pyrimido[4,5,6-kl]acridines. Synthesis, in vitro cytotoxicity and structure-activity relationships.
    Antonini I, Polucci P, Martelli S.
    Anticancer Drug Des; 1999 Oct 01; 14(5):451-9. PubMed ID: 10766300
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and structure-activity relationships of carbazole sulfonamides as a novel class of antimitotic agents against solid tumors.
    Hu L, Li ZR, Li Y, Qu J, Ling YH, Jiang JD, Boykin DW.
    J Med Chem; 2006 Oct 19; 49(21):6273-82. PubMed ID: 17034133
    [Abstract] [Full Text] [Related]

  • 8. Pyrazino[1,2-b]isoquinolines: synthesis and study of their cytostatic and cytotoxic properties.
    Ortín I, González JF, Cuesta Ede L, Manguan-García C, Perona R, Avendaño C.
    Bioorg Med Chem; 2008 Oct 01; 16(19):9065-78. PubMed ID: 18799316
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and antiproliferative activity of tyrphostins containing quinoline moieties.
    Brunton VG, Lear MJ, McKeown P, Robins DJ, Workman P.
    Anticancer Drug Des; 1996 Sep 01; 11(6):463-83. PubMed ID: 8836111
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and biological evaluation of cinnamido linked pyrrolo[2,1-c][1,4]benzodiazepines as antimitotic agents.
    Kamal A, Balakishan G, Ramakrishna G, Shaik TB, Sreekanth K, Balakrishna M, Rajender, Dastagiri D, Kalivendi SV.
    Eur J Med Chem; 2010 Sep 01; 45(9):3870-84. PubMed ID: 20554354
    [Abstract] [Full Text] [Related]

  • 11. The cytotoxicity of methyl protoneogracillin (NSC-698793) and gracillin (NSC-698787), two steroidal saponins from the rhizomes of Dioscorea collettii var. hypoglauca, against human cancer cells in vitro.
    Hu K, Yao X.
    Phytother Res; 2003 Jun 01; 17(6):620-6. PubMed ID: 12820229
    [Abstract] [Full Text] [Related]

  • 12. Biological profile of new apoptotic agents based on 2,4-pyrido[2,3-d]pyrimidine derivatives.
    Cordeu L, Cubedo E, Bandrés E, Rebollo A, Sáenz X, Chozas H, Victoria Domínguez M, Echeverría M, Mendivil B, Sanmartin C, Palop JA, Font M, García-Foncillas J.
    Bioorg Med Chem; 2007 Feb 15; 15(4):1659-69. PubMed ID: 17204425
    [Abstract] [Full Text] [Related]

  • 13. Chemosensitization and radiosensitization of human lung and colon cancers by antimitotic agent, ABT-751, in athymic murine xenograft models of subcutaneous tumor growth.
    Jorgensen TJ, Tian H, Joseph IB, Menon K, Frost D.
    Cancer Chemother Pharmacol; 2007 May 15; 59(6):725-32. PubMed ID: 16967299
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and antiproliferative activity of unsaturated quinoline derivatives.
    Montgomery GJ, McKeown P, McGown AT, Robins DJ.
    Anticancer Drug Des; 2000 Jun 15; 15(3):171-81. PubMed ID: 11049085
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and antiproliferative evaluation of 2,3-diarylquinoline derivatives.
    Tseng CH, Chen YL, Chung KY, Wang CH, Peng SI, Cheng CM, Tzeng CC.
    Org Biomol Chem; 2011 May 07; 9(9):3205-16. PubMed ID: 21423988
    [Abstract] [Full Text] [Related]

  • 16. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J, Oleschuk CJ, Guziec F, Guziec L, Fiterman DJ, Monterrosa C, Begleiter A.
    Cancer Chemother Pharmacol; 2002 Feb 07; 49(2):101-10. PubMed ID: 11862423
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and antitumor cytotoxicity evaluation of pyrido[4,3,2-de]quinolines and isoquinolino[6,5,4,3-cde]quinolines.
    Ding Q, Jia G, Lown JW.
    Anticancer Drug Des; 2000 Apr 07; 15(2):99-108. PubMed ID: 10901297
    [Abstract] [Full Text] [Related]

  • 18. Antitumor agents 6. Synthesis, structure-activity relationships, and biological evaluation of spiro[imidazolidine-4,3'-thieno[2,3-g]quinoline]-tetraones and spiro[thieno[2,3-g]quinoline-3,5'-[1,2,4]triazinane]-tetraones with potent antiproliferative activity.
    Bolognese A, Correale G, Manfra M, Esposito A, Novellino E, Lavecchia A.
    J Med Chem; 2008 Dec 25; 51(24):8148-57. PubMed ID: 19053767
    [Abstract] [Full Text] [Related]

  • 19. Cytotoxic activity and cell cycle analysis of quinoline alkaloids isolated from Haplophyllum canaliculatum Boiss.
    Varamini P, Javidnia K, Soltani M, Mehdipour AR, Ghaderi A.
    Planta Med; 2009 Nov 25; 75(14):1509-16. PubMed ID: 19551611
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and in vitro and in vivo antitumor activity of 2-phenylpyrroloquinolin-4-ones.
    Ferlin MG, Chiarelotto G, Gasparotto V, Dalla Via L, Pezzi V, Barzon L, Palù G, Castagliuolo I.
    J Med Chem; 2005 May 05; 48(9):3417-27. PubMed ID: 15857148
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.